MKI-1, an inhibitor of MASTL (microtubule-associated serine/threonine kinase-like) with an IC50 of 9.9 µM, exerts antitumor and radiosensitizer activities through PP2A activation in breast cancer[1].
Molecular Weight:
302.33
Purity:
98.07
CAS Number:
[1190277-80-5]
Formula:
C18H14N4O
Target:
MASTL
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
